Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate

We are Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate CAS:154330-68-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate
CAS.NO:154330-68-4
Synonyms:Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate
Ethyl 4-acetoxy-2-(ethylsulfanyl)-6,7-difluoroquinoline-3-carboxylate
Ethyl 4-acetoxy-2-(ethylsulfanyl)-6,7-difluoro-3-quinolinecarboxylate
ethyl 4-(acetyloxy)-2-(ethylsulfanyl)-6,7-difluoroquinoline-3-carboxylate
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 443.0±45.0 °C at 760 mmHg
Molecular Formula C16H15F2NO4S
Molecular Weight 355.356
Flash Point 221.7±28.7 °C
 
Specification:
Appearance:Light yellow to almost white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Prulifloxacin(CAS:123447-62-1).

Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Fluoro-3-methyl-5-nitropyridine Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.259214-56-7 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.cumene CAS:98-82-8 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
4-Acetylbenzoic acid View Details
(2S,3aR,7aS)-Octahydroindole-2-carboxylic acid View Details
Gonadorelin acetate View Details
Iminodibenzyl manufacturer 6-Methoxyguanine manufacturer 1,2-dioleoyl-3-trimethylammonium-propane chloride salt manufacturer 7-Azabenzotriazol-1-Yloxytris(Dimethylamino)Phosphonium Hexafluorophosphate manufacturer L-Alanine Methyl Ester Hydrochloride manufacturer